Anhui Fengyuan Pharmaceutical Co., Ltd.
000153.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.86B
Close$
$2.12
63.4% downside
Current Fair Value
63.4% downsideOvervalued by 63.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.86 Billion |
|---|---|
| Enterprise Value | $4.10 Billion |
| Dividend Yield | $0.10 (1.62%) |
| Earnings per Share | $0.21 |
| Beta | 0.42 |
| Outstanding Shares | 464,737,097 |
Return
| Return on Equity | 4.37% |
|---|---|
| Return on Assets | 1.84% |
| Return on Invested Capital | 1.91% |
Valuation & Multiples
| P/E Ratio | 30.33 |
|---|---|
| PEG | -291.7 |
| Price to Sales | 0.83 |
| Price to Book Ratio | 1.16 |
| Enterprise Value to Revenue | 1.17 |
| Enterprise Value to EBIT | 80.51 |
| Enterprise Value to Net Income | 43 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | 0.8 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Anhui Fengyuan Pharmaceutical Co., Ltd.
4,278 employees
CEO: Tianle Ru Established in Hefei, China in 1997, Anhui Fengyuan Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of a wide array of medicinal products. The co...